Kindred Biosciences (KIN) Tops Q2 EPS by 9c

Kindred Biosciences (NASDAQ: KIN) reported Q2 EPS of ($0.35), $0.09 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• SanDisk upgraded at JPMorgan after investor day; shares climb